Beirne Wealth Consulting Services, LLC Novartis Ag Transaction History

Beirne Wealth Consulting Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 28, 2020	SELL	$70.67 - $99.01 $156,463 - $219,208	-2,214 Closed	0 $0
Q4 2019 Jan 14, 2020	BUY	$84.35 - $95.37 $186,750 - $211,149	2,214 New	2,214 $210,000
Q3 2019 Nov 07, 2019	SELL	$85.54 - $94.26 $189,385 - $208,691	-2,214 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$75.4 - $92.8 $74,872 - $92,150	-993 Reduced 30.96%	2,214 $202,000
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $121,340 - $138,787	-1,611 Reduced 33.44%	3,207 $308,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $354,893 - $395,172	4,818 New	4,818 $413,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Beirne Wealth Consulting Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Beirne Wealth Consulting Services, LLC with notifications on news.